Palisades Hudson Asset Management’s Amgen AMGN Stock Holding History

Palisades Hudson Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Buy	+580	New	+$207K	0.08%	105
2024 Q4	–	Sell	-758	Closed	-$244K	–	106
2024 Q3	$244K	Buy	758 +96	+15%	+$31.4K	0.1%	86
2024 Q2	$207K	Sell	662 -125	-16%	-$36.7K	0.1%	88
2024 Q1	$224K	Hold	787	–	–	0.1%	87
2023 Q4	$227K	Sell	787 -525	-40%	-$143K	0.11%	85
2023 Q3	$352K	Hold	1,312	–	–	0.19%	61
2023 Q2	$291K	Hold	1,312	–	–	0.15%	70
2023 Q1	$317K	Sell	1,312 -23	-2%	-$5.65K	0.17%	69
2022 Q4	$350K	Buy	1,335 +13	+1%	+$3.48K	0.19%	68
2022 Q3	$298K	Sell	1,322 -50	-4%	-$12.1K	0.18%	70
2022 Q2	$334K	Buy	1,372 +30	+2%	+$7.35K	0.19%	66
2022 Q1	$324K	Buy	1,342 +39	+3%	+$8.96K	0.15%	80
2021 Q4	$293K	Hold	1,303	–	–	0.13%	91
2021 Q3	$277K	Hold	1,303	–	–	0.13%	89
2021 Q2	$318K	Hold	1,303	–	–	0.14%	83
2021 Q1	$324K	Sell	1,303 -82	-6%	-$19.6K	0.15%	76
2020 Q4	$318K	Hold	1,385	–	–	0.16%	71
2020 Q3	$352K	Hold	1,385	–	–	0.23%	63
2020 Q2	$327K	Hold	1,385	–	–	0.22%	64
2020 Q1	$281K	Hold	1,385	–	–	0.24%	60
2019 Q4	$334K	Sell	1,385 -40	-3%	-$8.82K	0.21%	65
2019 Q3	$276K	Hold	1,425	–	–	0.19%	72
2019 Q2	$262K	Hold	1,425	–	–	0.18%	79
2019 Q1	$271K	Sell	1,425 -300	-17%	-$57.3K	0.18%	76
2018 Q4	$336K	Hold	1,725	–	–	0.2%	71
2018 Q3	$357K	Sell	1,725 -220	-11%	-$43.4K	0.18%	75
2018 Q2	$359K	Hold	1,945	–	–	0.19%	68
2018 Q1	$332K	Hold	1,945	–	–	0.18%	75
2017 Q4	$338K	Hold	1,945	–	–	0.19%	74
2017 Q3	$362K	Hold	1,945	–	–	0.21%	67
2017 Q2	$335K	Hold	1,945	–	–	0.2%	72
2017 Q1	$319K	Hold	1,945	–	–	0.2%	64
2016 Q4	$285K	Hold	1,945	–	–	0.17%	68
2016 Q3	$325K	Hold	1,945	–	–	0.25%	56
2016 Q2	$296K	Sell	1,945 -297	-13%	-$46.2K	0.24%	62
2016 Q1	$336K	Hold	2,242	–	–	0.26%	56
2015 Q4	$363K	Hold	2,242	–	–	0.31%	45
2015 Q3	$310K	Hold	2,242	–	–	0.28%	53
2015 Q2	$344K	Sell	2,242 -222	-9%	-$35.6K	0.3%	48
2015 Q1	$393K	Hold	2,464	–	–	0.31%	41
2014 Q4	$392K	Buy	2,464 +40	+2%	+$6.23K	0.31%	44
2014 Q3	$340K	Buy	2,424 +480	+25%	+$62.7K	0.28%	55
2014 Q2	$230K	Hold	1,944	–	–	0.19%	64
2014 Q1	$240K	Hold	1,944	–	–	0.21%	61
2013 Q4	$222K	Hold	1,944	–	–	0.19%	60
2013 Q3	$218K	Buy	+1,944	New	+$211K	0.2%	56

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Palisades Hudson Asset Management's AMGN Position: Q1 2026 in Review

Palisades Hudson Asset Management opened a new position in Amgen (AMGN) in Q1 2026: 580 shares worth $204K. The stake represents 0.08% of the portfolio and ranks #105 among its holdings. This is a return to the name: Palisades Hudson Asset Management previously reported a position in AMGN as recently as Q3 2024.

Palisades Hudson Asset Management first reported a position in AMGN in Q3 2013 and has held it in 46 quarters since. The position peaked at $393K in Q1 2015. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Palisades Hudson Asset Management held 580 shares of Amgen worth $204K as of Q1 2026.
Amgen was a new Palisades Hudson Asset Management position in Q1 2026.
Amgen made up 0.08% of Palisades Hudson Asset Management's portfolio in Q1 2026, its #105 holding.
Palisades Hudson Asset Management first reported a position in Amgen in Q3 2013 and has held it in 46 quarters since.
Palisades Hudson Asset Management's Amgen position peaked at $393K in Q1 2015.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Palisades Hudson Asset Management's 13F filing for Q1 2026, filed 8 May 2026.